European Commission logo
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-24

The impact of treatment with acetylcholinesterase inhibitors on Europeans with Alzheimers disease

Objective

AChe I have been shown to afford modest benefits on cognition in AD patients. A systematic review by the Cochrane Collaboration states "the practical importance of these changes to patients is unclear" This study's primary objective is to find clinical evidence for the global efficacy of AChE I. The secondary aim is to develop a picture of the natural history of AD. These outcomes will provide a fundamental insight into the progression and treatment of AD aiding the formulation of European guidelines. This is a prospective 2 year observational study which co-ordinates the centralisation of patient data available within the individual centres. It does not require any modification in prescribing practice of participating centres. Patients will be recruited into either a treated or non-treated patient group and reviewed 6 monthly. The primary outcome measure is a deterioration of one level on the clinical dementia rating scale.

Fields of science

Programme(s)

Topic(s)

Call for proposal

Data not available

Funding Scheme

CON - Coordination of research actions

Coordinator

CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
EU contribution
No data
Address
Av. de Casselardit, 170
31300 TOULOUSE
France

See on map
Total cost
No data

Participants (30)

Share this page

Download

Last update: 13 June 2006

My Booklet

Permalink: https://cordis.europa.eu/project/id/QLK6-CT-2002-02645

European Union, 2024